Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

New Strategies to Enhance Smoking Cessation

University of Chicago · NCT06751927

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–75 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
94
US sites recruiting
1
Study start
April 24, 2025
Record last updated
June 11, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The study goal is to get feedback on ways researchers can communicate complex research findings on smoking cessation to better inform patients' decisions to use medication and/or quit smoking. This will help researchers and clinicians to provide effective, easy-to-implement treatments designed to address tobacco-related health disparities in Black and other racial/ethnic subgroups. It will also help improve health literacy to change misperceptions and mistrust on uptake of varenicline and other medication for quitting smoking. A professionally made video will explain research findings relevant for varenicline's mechanisms and outcomes relative to other treatment options.

There are 2 parts to this study:

  • Part 1: Focus Group to help develop the educational tool intervention
  • Part 2: Randomized portion of study. In this part of the study, participants will be randomized (like flip of coin) to take part in receive the experimental educational intervention or usual methods to help stop smoking. Participants in either arm can choose to receive varenicline and it will be provided as part of study.

Being studied: Educational Video

Conditions: Smoking Cessation

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Patients must smoke at least 10 cigarettes/day and do not currently use a smoking cessation medication.
  • Ages 18-75.
  • Agree to complete surveys and measures within study.
  • Ability to understand English and the willingness to sign a written informed consent document.

Exclusion Criteria

  • Patients who are receiving any other smoking cessation medications.
  • Patients who are pregnant and/or lactating.
  • Patients with psychiatric contraindications that can prevent adherence to protocol or use of intervention tools in study. For inclusivity on trial, psychiatric contraindications and ability for patient to participate in trial will be assessed on an individual basis by study investigator.
  • Patients who have a contraindication with varenicline.

Recruiting US locations

  • University of Chicago

    Chicago, IL 60637

    Site contact: Clinical Trials Intake · 855-702-8222 · cancerclinicaltrials@bsd.uchicago.edu

Study contacts (from the official record)

  • Clinical Trials Intake · 1-855-702-8222 · cancerclinicaltrials@bsd.uchicago.edu
All smoking & vaping studies in Illinois →
New Strategies to Enhance Smoking Cessation (NCT06751927) | Bored Studies